News Earnings Prism Medico and Pharmacy Limited Schedules Board Meeting for February 13, 2026 to Consider Q3FY26 Financial ResultsPrism Medico and Pharmacy Limited Schedules Board Meeting for February 13, 2026 to Consider Q3FY26 Financial Results
Prism Medico and Pharmacy Limited has scheduled a board meeting for February 13, 2026, at 01:00 P.M. at its registered office in Himachal Pradesh to consider and approve Q3FY26 unaudited standalone financial results for the quarter ended December 31, 2025. The meeting agenda includes reviewing financial results with Limited Review Report as per SEBI Regulation 33 and discussing routine business matters. The company has notified both BSE (scrip code: 512217) and MSEI (symbol: PRISMMEI) in compliance with regulatory requirements.
*this image is generated using AI for illustrative purposes only.
Prism Medico & Pharmacy Limited has announced that its Board of Directors will convene on February 13, 2026, to review and approve the company's third quarter financial performance for FY26. The meeting represents a key milestone in the company's quarterly reporting cycle as it prepares to disclose its financial results for the period ended December 31, 2025.
Meeting Details and Venue
The board meeting is scheduled to commence at 01:00 P.M. at the company's registered office located at Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030. The announcement was made on February 7, 2026, providing stakeholders with adequate notice as required under regulatory guidelines.
| Meeting Parameter: | Details |
|---|---|
| Date: | February 13, 2026 |
| Time: | 01:00 P.M. |
| Venue: | Registered Office, Suketi Road, Kala Amb |
| Location: | Sirmaur, Himachal Pradesh-173030 |
Key Agenda Items
The board meeting will focus on two primary areas of business. The directors will consider, approve and take on record the unaudited standalone financial results of the company along with the Limited Review Report for the quarter ended December 31, 2025. This review process aligns with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, the board will consider and discuss any other routine matters or business pertaining to the company's operations.
Regulatory Compliance and Stock Exchange Notification
Prism Medico and Pharmacy Limited has fulfilled its regulatory obligations by notifying both stock exchanges where its shares are listed. The company informed BSE Limited, where it trades under scrip code 512217, and Metropolitan Stock Exchange of India Limited (MSEI), where it is listed under the symbol PRISMMEI. This notification complies with Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Exchange Details: | Information |
|---|---|
| BSE Scrip Code: | 512217 |
| MSEI Symbol: | PRISMMEI |
| ISIN: | INE730E01016 |
| CIN: | L24100HP2002PLC009299 |
Company Leadership
The meeting notification was signed by Davender Singh, Director of the company, bearing DIN: 09447213. The company maintains its investor grievance email at investor.grievance@prismmedico.com for stakeholder communications and queries related to corporate matters.
Historical Stock Returns for Prism Medico & Pharmacy
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.79% | +13.31% | -3.50% | +38.46% | +12.21% | -33.92% |
18
